Kawai, R.; Sugita, Y.; Suzumura, T.; Hattori, T.; Yoshida, W.; Kubo, K.; Maeda, H.
Melanoma Inhibitory Activity and Melanoma Inhibitory Activity 2 as Novel Immunohistochemical Markers of Oral Epithelial Dysplasia. J. Clin. Med. 2021, 10, 3661.
https://doi.org/10.3390/jcm10163661
AMA Style
Kawai R, Sugita Y, Suzumura T, Hattori T, Yoshida W, Kubo K, Maeda H.
Melanoma Inhibitory Activity and Melanoma Inhibitory Activity 2 as Novel Immunohistochemical Markers of Oral Epithelial Dysplasia. Journal of Clinical Medicine. 2021; 10(16):3661.
https://doi.org/10.3390/jcm10163661
Chicago/Turabian Style
Kawai, Ryoko, Yoshihiko Sugita, Toshikatsu Suzumura, Takehiro Hattori, Waka Yoshida, Katsutoshi Kubo, and Hatsuhiko Maeda.
2021. "Melanoma Inhibitory Activity and Melanoma Inhibitory Activity 2 as Novel Immunohistochemical Markers of Oral Epithelial Dysplasia" Journal of Clinical Medicine 10, no. 16: 3661.
https://doi.org/10.3390/jcm10163661
APA Style
Kawai, R., Sugita, Y., Suzumura, T., Hattori, T., Yoshida, W., Kubo, K., & Maeda, H.
(2021). Melanoma Inhibitory Activity and Melanoma Inhibitory Activity 2 as Novel Immunohistochemical Markers of Oral Epithelial Dysplasia. Journal of Clinical Medicine, 10(16), 3661.
https://doi.org/10.3390/jcm10163661